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Abstract 
Objectives 
To examine the associations between severity of pain and anxiety in a community population 
reporting joint pain, and investigate management of joint pain in the presence of co-morbid anxiety. 
Methods 
A population survey of people aged ≥45 years registered with eight general practices in Cheshire, 
Shropshire, and Staffordshire, UK. Respondents were asked to report pain intensity in their hands, 
hips, knees and feet (numeric rating scale), anxiety symptoms (GAD-7 scale), and guideline-
recommended treatments used to manage pain. Clinical anxiety was defined by a GAD-7 score of 10 
or more.  
Results 
11,222 respondents with joint pain were included in this analysis. 1,802 (16.1%) reported clinical 
anxiety. Respondents reporting more severe pain were more likely to report clinical anxiety (severe 
vs. mild pain odds ratio [OR] 5.36, 95% confidence interval [CI] 4.56,6.31). Number of pain sites was 
also positively associated with clinical anxiety (four vs. one site OR 3.64, 95%CI 3.09,4.30). Those 
with clinical anxiety were less likely to undertake general fitness exercises (OR 0.60, 95%CI 
0.52,0.70), but more likely to diet (OR 1.43, 95% CI 1.21,1.69), use walking aids (OR 1.53, 95%CI 
1.32,1.77) and assistive devices (OR 1.24, 95%CI 1.04,1.49), and more likely to use opioids (OR 1.34, 
95%CI 1.18,1.52). 
Conclusion 
Anxiety is common amongst patients presenting to primary care with joint pain. Patients with 
anxiety are likely to manage their joint pain differently to those without. Case-finding to identify and 
treat anxiety would be appropriate in this population, with caution about opioid prescribing and 
consideration of exercise as an intervention. 
Keywords 
Analgesia, anxiety, joint pain, osteoarthritis, primary health care, questionnaire survey 
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Background 
Joint pain due to osteoarthritis (OA) is a common presenting complaint in primary care. In North 
Staffordshire, United Kingdom, one in seven primary care consultations is estimated to be for a 
musculoskeletal problem (Jordan et al., 2010) and 10% of the population aged ≥45 years is recorded 
annually as having a consultation with OA or joint pain (Jordan et al., 2014). The National Institute 
for Health and Care Excellence (NICE) guidance states that OA can be diagnosed clinically, without 
further investigations, in people over 45 years old who have activity-related joint pain, no more than 
thirty minutes of morning stiffness, and no atypical features suggesting an alternative diagnosis 
(National Institute for Health & Care Excellence, 2014). NICE recommends that patients with OA 
should have an agreed self-management strategy, with core management including access to 
appropriate information, physical activity and exercise, and support for weight loss if needed (body 
mass index (BMI) ≥25 kgm-2) (National Institute for Health & Care Excellence, 2014). However, 
pharmacological treatments that are recommended as an adjunct to core treatments often precede 
or replace these in management of joint pain (Jinks et al., 2011; Porcheret, Jordan, Jinks, Croft, & 
Primary Care Rheumatology, 2007). Exercise as a treatment for OA is well-known (Fransen et al., 
2015) and has also been found to be effective in anxiety disorders, albeit less so than 
antidepressants (Jayakody, Gunadasa, & Hosker, 2014). 
 
Chronic pain, such as joint pain, is often associated with co-morbid anxiety disorders (Axford et al., 
2010; McWilliams, Cox, & Enns, 2003; McWilliams, Goodwin, & Cox, 2004; Scott et al., 2007). Anxiety 
disorders are associated with increased frequency of consultation in primary care (Bélanger, 
Ladouceur, & Morin, 2005), but people often present with pain and seldom with psychological 
symptoms (Garcia-Campayo, Caballero, Perez, & Lopez, 2012; Wittchen et al., 2002). Recognition of 
anxiety disorders in primary care has been identified to be suboptimal (Wittchen et al., 2002), and 
the receipt of a physical diagnosis reduces the likelihood of being diagnosed with anxiety (Ballenger 
et al., 2001). Many patients suffer clinically significant symptoms without meeting the diagnostic 
criteria for an anxiety disorder (Beesdo et al., 2009; Haller, Cramer, Lauche, Gass, & Dobos, 2014), 
and general practitioners (GPs) may be more confident to recognise anxiety symptoms than to make 
specific anxiety diagnoses (Walters, Rait, Griffin, Buszewicz, & Nazareth, 2012). Anxiety can be 
diagnosed formally by a structured clinical assessment, such as the Composite International 
Diagnostic Interview (World Health Organization, 1990), but screening tools have also been used in 
research to identify what may be termed ‘clinical anxiety’. The GAD-7 scale quantifies anxiety 
symptoms (Spitzer, Kroenke, Williams, & Lowe, 2006) and can be used to screen for generalised 
anxiety disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder in primary 
care (Kroenke, Spitzer, Williams, Monahan, & Lowe, 2007) and the general population (Lowe et al., 
2008). Although it cannot be used to assign specific anxiety disorder diagnoses, a threshold score of 
10 or more may be used to classify people as having ‘clinical anxiety’ (Bair, Wu, Damush, Sutherland, 
& Kroenke, 2008) with a sensitivity of 89% and specificity of 82% for generalised anxiety disorder 
(Kroenke et al., 2007). It is quick to administer (Williams, 2014) and has previously been used to 
determine the presence of anxiety in people with joint pain (Bair et al., 2008). 
 
There is evidence that anxiety and depression comorbidity is associated with worse pain amongst 
primary care patients with chronic musculoskeletal pain (Bair et al., 2008; de Heer et al., 2014). A 
meta-analysis of the prevalence of depression and anxiety in people with OA suggested that over 
20% of OA patients have anxiety, with a relative risk estimated at 1.35 amongst people with OA 
compared to those without, though this did not achieve statistical significance (Stubbs, Hurley, & 
Smith, 2015). Factors within clinical OA associated with an increased risk of clinical anxiety require 
further exploration. Any associations between different primary care management processes of care 
and clinical anxiety are also unknown. The objectives of this analysis were (i) to examine the 
relationship between pain (severity, location, and number of sites affected) and clinical anxiety in a 
community population reporting joint pain, and (ii) to investigate the management of joint pain 
(self-reported processes of care) in the presence of co-morbid clinical anxiety. 
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Method 
The Management of Osteoarthritis in Consultations Study (MOSAICS) was a programme of research 
to develop a model primary care consultation for OA, and test its feasibility and acceptability in 
primary care. A cross-sectional population survey formed a key component of this programme. The 
full description of the methods, outcome measures, and analysis plan have been reported in the 
protocol (Dziedzic et al., 2014). In brief, participants were recruited from eight general practices in 
the North West Midlands and Cheshire. Between May 2011 and February 2012, patients registered 
with the participating practices who were aged ≥45 years, did not have a diagnosis of inflammatory 
arthritis or serious co-morbidity, and did not have an inability to attend the surgery or consent to the 
research, were sent an invitation to complete the MOSAICS population survey.  
 
Respondents were asked to report the intensity of pain in their hands, hips, knees and feet during 
the previous month on a numeric rating scale from 0 to 10. As supported by the patient and public 
involvement group for quantifying multi-site pain, a ‘worst pain’ score was calculated as the greatest 
value given for any joint (Finney, Dziedzic, M. Lewis, S. Ryan, & Healey, 2015). Pain scores were 
classified as none (0), mild (1 to 3), moderate (4 to 6), and severe (7 to 10) pain, as described in 
previous studies of musculoskeletal pain (Salaffi, Ciapetti, & Carotti, 2012) and in primary care 
(Krebs, Carey, & Weinberger, 2007). 
 
Anxiety symptoms were assessed using the GAD-7 scale. This score is calculated from the frequency 
of seven anxiety symptoms in the previous two weeks and gives a result from 0 to 21, where higher 
scores indicate worse anxiety (Spitzer et al., 2006). Where one item was missing, we used the mean 
of the other six responses for the missing value; if more than one item was missing, no total GAD-7 
score was calculated (Kroenke et al., 2007). 
 
Management of joint pain was assessed using the Knee Pain Screening Tool (KNEST) (Jinks, Jordan, 
Ong, & Croft, 2004) expanded for use in the hands, hips, knees and feet, and included treatments 
listed in national guidelines for OA management (Box 1) (Conaghan, Dickson, Grant, & Guideline 
Development, 2008). For each treatment, respondents were asked to state whether they had used it 
in the previous twelve months, and whether it had been obtained from the National Health Service 
(NHS), another source, or both. 
 






Podiatry or chiropody  
Hospital specialist 




Muscle-strengthening exercises  
General fitness exercises  
Dieting to lose weight 
Written information about treatments 
Written information about self-management 
Written information about osteoarthritis 
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Relatively safe pharmaceutical options 
Paracetamol 
Anti-inflammatory creams or gels 
 
Adjunctive treatments 
Drugs on prescription 
Joint operation  
Joint injection  
Capsaicin cream  
Anti-inflammatory tablets 
Stronger painkillers (e.g. opioids) 
Transcutaneous electrical nerve stimulation 
Warmth, heat or cold 
Walking aids (e.g. walking sticks) 
Shock-absorbing shoes or insoles 
Appliances and supports (e.g. knee brace) 
Assistive devices (e.g. kitchen gadgets)  
 
Treatments that are not recommended 
Acupuncture 
Glucosamine or chondroitin sulphate 
 
The Index of Multiple Deprivation 2010 (IMD) was derived for each respondent from their post code. 
This ranks neighbourhood deprivation through seven domains: income; employment; health and 
disability; education, skills and training; housing and services; crime and disorder; and living 
environment (HM Government Department for Communities and Local Government, 2011). 
Information about other potential confounding factors were included as questions in the survey 
(Dziedzic et al., 2014). 
Analysis 
This analysis included all respondents who completed sufficient items for a total GAD-7 score to be 
calculated, and reported a worst pain score of at least 1, indicating that they had at least some joint 
pain. Respondents were dichotomised to the presence of clinical anxiety at or above a GAD-7 
threshold score of 10 (Bair et al., 2008).  
 
The association of anxiety with joint pain intensity, with location of pain, and with number of pain 
sites were determined first unadjusted, and then adjusted for potential confounding variables (age, 
sex, marital status, living alone, employment status, IMD, BMI and registered general practice) using 
binary logistic regression and presented as odds ratios (OR) with 95% confidence intervals (CI). The 
association of self-reported use of each treatment for joint pain with clinical anxiety was also 
determined using binary logistic regression analysis, adjusting for worst pain intensity, number of 
joints with a pain score of at least one, age, sex, marital status, living alone, employment status, 
IMD, BMI and general practice. Dieting to lose weight was analysed separately for all respondents 
and for those with a BMI of 25 kgm-2 or greater. Analysis was repeated, stratified by source of 
treatment (NHS vs. non-NHS). 
 
Results 
The survey was mailed to 28,443 people, and 15,083 were returned completed (response rate 
53.0%). 11,534 (76.5%) respondents reported pain in at least one joint in the previous month. Of 
these, 11,222 (97.3%) completed sufficient items for a GAD-7 to be calculated. These 11,222 formed 
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the study population for this analysis (Table 1). 
 
Table 1. Demographic characteristics of respondents 
 Respondents 
n (%) 
All respondents 11222 
Sex  
Women 6258 (55.8%) 
Men 4964 (44.2%) 
Age  
45-64 6023 (53.7%) 
65-74 3072 (27.4%) 
75-84 1717 (15.3%) 
85+ 410 (3.7%) 
Lives Alone  
No 8723 (77.7%) 
Yes 2237 (19.9%) 
Missing 262 (2.3%) 
Marital status  
Single 534 (4.8%) 
Married or cohabiting 8205 (73.1%) 
Separated or divorced 1026 (9.1%) 
Widowed 1395 (12.4%) 
Missing 62 (0.6%) 
Employment  
Employed 3776 (33.7%) 
Unemployed and other† 1533 (13.7%) 
Retired 5675 (50.6%) 
Missing 238 (2.1%) 
Body mass index  
Underweight (<18.5 kg/m2) 100 (0.9%) 
Normal range (18.5–25 kg/m2) 3705 (33.0%) 
Pre-obese (25–30 kg/m2) 4372 (39.0%) 
Obese (≥30 kg/m2) 2640 (23.5%) 
Missing 405 (3.6%) 
Index of Multiple Deprivation:  
 Most deprived 2348 (20.9%) 
 2 2149 (19.2%) 
 3 2289 (20.4%) 
 4 
 Least deprived 
2242 (20.0%) 
2189 (19.5%) 
 Missing 5 (<0.1%) 
† Includes ‘Not working due to ill health’, ‘Unemployed/seeking work’, 
‘Housewife’ and ‘Other’ 
 
The knee was the most common site of reported joint pain (7,736 respondents [68.9%] reporting at 
least mild pain). The median GAD-7 score was 3 (inter-quartile range [IQR] 0–7). 3,588 (32.0%) 
respondents had a GAD-7 score of 0. 1,802 (16.1%) respondents reported a score of 10 or more, and 
so were classified as having clinical anxiety. Increasing pain intensity was associated with an 
increased prevalence of clinical anxiety (adjusted OR for severe vs. mild worst pain 5.36, 95% CI 
4.56,6.31), as was a greater number of joint sites affected by at least mild pain (adjusted OR for four 
sites vs. one site 3.64, 95% CI 3.09,4.30; Table 2). 
 
Compared to the knee, clinical anxiety was more frequent in people with pain at the foot (adjusted 
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Table 2. Association of severity of joint pain, location and number of painful joints with clinical 
anxiety. 
   Odds ratio (95% CI) of having clinical anxiety† 
n = 11222 
All respondents; n 
(column %) 
Respondents with 
clinical anxiety†;  
n (row %) Unadjusted Adjusted‡ 
Worst pain     
Mild 3925 (35.0%) 238 (6.1%) 1§ 1§ 
Moderate 3767 (33.6%) 511 (13.6%) 2.43 (2.07–2.86) 2.20 (1.86–2.61) 
Severe 3530 (31.5%) 1053 (29.8%) 6.59 (5.67–7.65) 5.36 (4.56–6.31) 
Hand pain     
None 4275 (38.1%) 460 (10.8%) 1§ 1§ 
Mild 2975 (26.5%) 309 (10.4%) 0.96 (0.83–1.12) 0.88 (0.75–1.04) 
Moderate 2078 (18.5%) 480 (23.1%) 2.49 (2.16–2.87) 2.11 (1.81–2.46) 
Severe 1213 (10.8%) 451 (37.2%) 4.91 (4.22–5.71) 3.72 (3.15–4.40) 
Missing 681 (6.1%) 102 (15.0%) - - 
Hip pain     
None 4905 (43.7%) 532 (10.8%) 1§ 1§ 
Mild 2419 (21.6%) 258 (10.7%) 0.98 (0.84–1.15) 0.98 (0.83–1.16) 
Moderate 1955 (17.4%) 437 (22.4%) 2.37 (2.06–2.72) 2.07 (1.78–2.41) 
Severe 1264 (11.3%) 443 (35.0%) 4.44 (3.83–5.13) 3.48 (2.95–4.09) 
Missing 679 (6.1%) 132 (19.4%) - - 
Knee pain     
None 2979 (26.6%) 340 (11.4%) 1§ 1§ 
Mild 3354 (29.9%) 318 (9.5%) 0.81 (0.69–0.96) 0.80 (0.67–0.95) 
Moderate 2626 (23.4%) 452 (17.2%) 1.61 (1.39–1.88) 1.42 (1.20–1.67) 
Severe 1756 (15.7%) 613 (34.9%) 4.16 (3.58–4.83) 3.45 (2.92–4.07) 
Missing 507 (4.5%) 79 (15.6%) - - 
Foot pain     
None 4791 (42.7%) 477 (10.0%) 1§ 1§ 
Mild 2317 (20.7%) 269 (11.6%) 1.19 (1.01–1.39) 1.11 (0.94–1.32) 
Moderate 1979 (17.6%) 423 (21.4%) 2.46 (2.13–2.84) 2.10 (1.80–2.45) 
Severe 1505 (13.4%) 530 (35.2%) 4.92 (4.27–5.67) 3.93 (3.36–4.60) 
Missing 630 (5.6%) 103 (16.3%) - - 
Number of joint sites with at least mild pain  
1 3456 (30.8%) 305 (8.8%) 1§ 1§ 
2 3295 (29.4%) 434 (13.2%) 1.57 (1.34–1.83) 1.45 (1.23–1.72) 
3 2489 (22.2%) 442 (17.8%) 2.33 (1.91–2.61) 1.93 (1.63–2.29) 
4 1982 (17.7%) 621 (31.3%) 4.71 (4.05–5.48) 3.64 (3.09–4.30) 
Number of joint sites with at least moderate pain  
0 3925 (35.0%) 238 (6.1%) 1§ 1§ 
1 3133 (27.9%) 405 (12.9%) 2.30 (1.95–2.72) 2.14 (1.79–2.56) 
2 2103 (18.7%) 420 (20.0%) 3.87 (3.26–4.58) 3.36 (2.80–4.03) 
3 1207 (10.8%) 372 (30.8%) 6.90 (5.77–8.26) 5.75 (4.73–7.00) 
4 854 (7.6%) 367 (43.0%) 11.67 (9.67–14.10) 8.74 (7.09–10.79) 
Number of joint sites with severe pain  
0 7692 (68.5%) 749 (9.7%) 1§ 1§ 
1 2104 (18.8%) 477 (22.7%) 2.72 (2.39–3.09) 2.44 (2.12–2.80) 
2 865 (7.7%) 302 (34.9%) 4.97 (4.24–5.83) 4.34 (3.64–5.17) 
3 340 (3.0%) 140 (41.2%) 6.49 (5.16–8.16) 4.71 (3.64–6.10) 
4 221 (2.0%) 134 (60.6%) 14.28 (10.79–18.89) 10.99 (8.01–15.07) 
Sites 
Knee 2968 (26.5%) 394 (13.3%) 1 1 
Hip 1773 (15.8%) 261 (14.5%) 1.13 (0.95-1.34) 1.06 (0.88-1.28) 
Hand 1807 (16.1%) 284 (15.8%) 1.22 (1.03-1.44) 1.20 (1.00-1.43) 
Foot 1926 (17.2%) 329 (17.1%) 1.35 (1.15-1.58) 1.35 (1.14-1.61) 
Multiple 2748 (24.5%) 534 (19.4%) 1.58 (1.37- 1.82) 1.39 (1.19-1.63) 
† Clinical anxiety defined as GAD-7 score ≥10 
‡ Adjusted for age, sex, marital status, living alone, employment status, body mass index, index of multiple deprivation 
2010, and general practice 
§ Reference category 
CI=confidence interval 
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4,449 (39.6%) respondents reported visiting their GP with a joint problem in the year before 
completing the questionnaire (Table 3). Of these, 1,006 (22.6%) reported clinical anxiety. 
Respondents with anxiety were significantly more likely to report using each consultation option 
listed in the KNEST instrument except physiotherapy, podiatry, and osteopathy (Table 3). There was 
no statistically significant difference between respondents with and without clinical anxiety in 
reported use of NHS or private physiotherapy services. 
 
Table 3. Association of type of consultation for joint pain with clinical anxiety 
 Frequency of use  
Consultations 
Respondents with clinical 
anxiety† 
n (%) 
Respondents without clinical 
anxiety† 
n (%) 
Odds ratio (95% CI) ‡ of use 
with clinical anxiety† 
General practitioner§ 1006 (22.6%) 3443 (77.4%) 1.13 (1.00–1.28) 
Practice nurse§ 277 (33.4%) 553 (66.6%) 1.58 (1.31–1.91) 
Physiotherapy 390 (20.3%) 1533 (79.7%) 1.07 (0.92–1.23) 
Occupational therapy 90 (31.8%) 193 (68.2%) 1.52 (1.13–2.06) 
Podiatry or chiropody  305 (21.8%) 1093 (78.2%) 1.13 (0.96–1.33) 
Hospital specialist 452 (24.4%) 1404 (75.6%) 1.22 (1.06–1.41) 
Osteopath or 
chiropractor  
108 (15.5%) 591 (84.5%) 0.83 (0.65–1.06) 
Community pharmacy 237 (25.9%) 677 (74.1%) 1.44 (1.20–1.72) 
† Clinical anxiety defined as GAD-7 score ≥10 
‡ Compared to use by respondents without clinical anxiety, adjusted for worst pain score, number of joint-pain sites, 
age, sex, marital status, living alone, employment status, body mass index, index of multiple deprivation 2010, and 
general practice 
§ Not all respondents completed this question so denominator <11 222 
CI=confidence interval 
 
The most frequently reported treatments were paracetamol and topical anti-inflammatories. 
Participants with clinical anxiety were significantly more likely to report using walking aids or strong 
painkillers such as opioids, and less likely to do general fitness exercises or muscle-strengthening 
exercises (Table 4). Few respondents reported dieting to lose weight, but this was reported by a 
greater proportion of those with clinical anxiety than without. This pattern was true for all 
respondents and for those with a raised BMI. Rates of reporting receipt of written information were 
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Table 4. Treatments used by respondents who reported joint pain, with and without anxiety. 








Odds ratio (95% CI) ‡ of use in 
respondents with clinical anxiety† 
Core treatments 
Muscle-strengthening 
exercises  362 (20.1%) 1793 (19.0%) 0.84 (0.72–0.97) 
General fitness exercises  287 (15.9%) 2316 (24.6%) 0.60 (0.52–0.70) 
Dieting to lose weight 301 (16.7%) 759 (8.1%) 1.43 (1.21–1.69) 
Respondents with 
BMI≥25 kg/m2 248 (20.9%) 562 (9.7%) 1.51 (1.25–1.82) 
Written information about:    
Treatments 147 (8.2%) 573 (6.1%) 0.95 (0.76–1.18) 
Self-management 266 (14.8%) 963 (10.2%) 0.97 (0.82–1.15) 
Osteoarthritis 208 (11.5%) 578 (6.1%) 1.18 (0.97–1.43) 
Relatively safe pharmaceutical options 
Paracetamol 1130 (62.7%) 4767 (50.6%) 1.14 (1.01–1.28) 
Anti-inflammatory creams 
or gels 889 (49.3%) 3735 (39.6%) 1.06 (0.94–1.19) 
Adjunctive treatments 
Drugs on prescription 982 (54.5%) 3192 (33.9%) 1.27 (1.12–1.44) 
Joint operation  128 (7.1%) 437 (4.6%) 1.02 (0.81–1.30) 
Joint injection  178 (9.9%) 486 (5.2%) 1.19 (0.97–1.47) 
Capsaicin cream  50 (2.8%) 90 (1.0%) 1.35 (0.89–2.07) 
Anti-inflammatory tablets 703 (39.0%) 3704 (39.3%) 0.79 (0.70–0.90) 
Stronger painkillers (e.g. 
opioids) 796 (44.2%) 2167 (23.0%) 1.34 (1.18–1.52) 
TENS 168 (9.3%) 492 (5.2%) 0.96 (0.78–1.20) 
Warmth, heat or cold 700 (38.8%) 2621 (27.8%) 1.04 (0.92–1.18) 
Walking aids 625 (34.7%) 1457 (15.5%) 1.53 (1.32–1.77) 
Shock-absorbing shoes or 
insoles 338 (18.8%) 1314 (13.9%) 1.03 (0.88–1.20) 
Appliances and supports 322 (17.9%) 1190 (12.6%) 0.98 (0.83–1.14) 
Assistive devices 320 (17.8%) 699 (7.4%) 1.24 (1.04–1.49) 
Treatments that are not recommended 
Acupuncture 85 (4.7%) 267 (2.8%) 1.19 (0.90-1.59) 
Glucosamine or chondroitin 
sulphate 298 (16.5%) 2002 (21.3%) 0.66 (0.56–0.77) 
† Clinical anxiety defined as GAD-7 score ≥10 
‡ Compared to use by respondents without clinical anxiety, adjusted for worst pain score, number of joint-pain sites, 
age, sex, marital status, living alone, employment status, body mass index, index of multiple deprivation 2010, and 
general practice 
CI=confidence interval; TENS=Transcutaneous electrical nerve stimulation 
 
Reported used of paracetamol was significantly different between those with and without clinical 
anxiety (OR 1.14; 95% CI 1.01, 1.28), and those with clinical anxiety were more likely than those 
without anxiety to have it prescribed as an NHS treatment (558 [31.0%] vs. 1,438 [15.3%], adjusted 
OR 1.43, 95% CI 1.24–1.65) and less likely to obtain it independently (643 [35.7%] vs. 3,591 [38.1%], 
adjusted OR 0.88, 95% CI 0.78–0.99). Despite not being recommended in NICE guidance, 
glucosamine or chondroitin sulphate were used by one in five respondents, but usage was less 
common in those with clinical anxiety. 
Discussion 
From a community sample of 11,222 people reporting joint pain, we have shown a significant 
association between joint pain intensity and anxiety severity, which is consistent with previous 
literature (Bair et al., 2008; de Heer et al., 2014). Whatever level of pain was reported, anxiety was 
more common with increasing number of pain sites affected. The association of the hand and foot 
sites with clinical anxiety is a new finding. This may partly reflect the nature of foot OA as a relatively 
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“neglected” site in terms of evidence for effective treatments (Conaghan, Kloppenburg, Schett, 
Bijlsma, & committee, 2014). Respondents with clinical anxiety were less likely to report the use of 
core non-pharmacological joint-pain treatments of muscle-strengthening exercises and general 
fitness exercises, and less likely to use oral anti-inflammatory medications, but were more likely to 
use paracetamol and opioids. 
 
At over 16% (n=1802), the prevalence of clinical anxiety amongst patients reporting joint pain in this 
study is similar to the total proportion (16.2%) of people meeting the diagnostic criteria for a 
common mental disorder in a household survey in 2007 (McManus, Meltzer, Brugha, Bebbington, & 
Jenkins, 2009); it is greater than the proportion of people identified by the same survey as having 
mixed anxiety & depression (9.0%) or generalised anxiety disorder (4.4%). It is a little lower than the 
pooled prevalence of anxiety symptoms in people with OA (21.3%) identified by Stubbs et al. 
(Stubbs, Aluko, Myint, & Smith, 2016). 
 
The impact of OA on patients’ lives is complex and multi-factorial (Creamer, Lethbridge-Cejku, & 
Hochberg, 2000). Anxiety and pain can perpetuate each other (Gerrits et al., 2012; Teh et al., 2009) 
and acute anxiety is associated with increased perception of pain (Goffaux et al., 2011; Saracoglu, 
Unsal, Taskin, Sevincok, & Karaman, 2012). Appropriate management of both anxiety and pain may 
be required to achieve satisfactory outcomes. Regular physical activity can improve symptoms of 
joint pain and is associated with a lower prevalence of generalised anxiety disorder (Muhsen, Lipsitz, 
Garty-Sandalon, Gross, & Green, 2008). However, people with anxiety regarding their pain are 
known to restrict their activities (Nicolson, Caplan, Williams, & Stern, 2009). A causal relationship 
between anxiety and pain cannot be inferred from our results, and the association could reflect a 
combination of both more anxiety amongst those with less regular exercise, and more limited 
activities in those with more pain. 
 
Opioids may be perceived to be useful by people with anxiety due to their anxiolytic properties 
(Colasanti, Rabiner, Lingford-Hughes, & Nutt, 2011) but this effect seems to be transient (Howe & 
Sullivan, 2014). Opioid use has been associated with worse outcomes within an intervention for 
anxiety (Roy-Byrne et al., 2013). Although self-reported use of opioids in this survey was greater in 
people identified as having clinical anxiety, we cannot draw firm conclusions about differences in 
requests for opioid treatment, any associated impact on anxiety severity, or whether the association 
reflected a difference in management recommended or prescribed by the GP.  
 
NICE guidance on the management of OA emphasises the importance of a self-management strategy 
(National Institute for Health & Care Excellence, 2014). A randomised controlled trial found that a 
self-management educational programme for OA in primary care reduced anxiety symptoms, even 
though that trial did not show a significant effect on pain (Buszewicz et al., 2006). Our results 
suggest that people with clinical anxiety might be less likely to obtain treatments independently and 
more likely to use NHS-prescribed treatment. Higher levels of anxiety are also associated with lower 
income levels (Lejtzén, Sundquist, Sundquist, & Li, 2014). We might expect people with lower 
income to be less able to pay for private provision, and they are more likely to receive NHS-
prescribed medications free of charge (NHS Choices, 2013), which might influence their help-
seeking.  
 
There is some evidence that a collaborative care approach including brief, low-intensity 
psychological therapy in primary care can reduce the severity of depression and anxiety, as well as 
improve self-management of chronic conditions (diabetes and cardiovascular disease) (Coventry et 
al., 2015). With suitable case-finding for anxiety symptoms in people with joint pain, provision of or 
referral for such intervention could usefully be considered, such as that being tested in the ENHANCE 
study (Healey et al., 2015).  
Anxiety and the management of joint pain     Page 11 of 17 
 
This was a pragmatic study, including a large number of people living in the community with 
symptoms of joint pain and anxiety. It is the first study to investigate comprehensive management 
options recommended by national guidance for OA pain in the presence of anxiety. Our 
questionnaire data were not intended to assign specific OA or anxiety disorder diagnoses. Instead 
we focussed on the symptoms with which patients are likely to present to their GPs and grouped 
people into clinical OA or anxiety on the basis of reported symptoms. The majority of this survey 
population would be expected to meet the NICE criteria for a clinical diagnosis of OA. This survey 
was not designed to determine the odds of clinical anxiety in people with joint pain relative to the 
population generally.  
 
The design of a cross-sectional paper-based survey allowed a large number of people from a 
primary-care population to participate. The response rate of 53% is typical for a population-based 
postal survey (Hill, Roberts, Ewings, & Gunnell, 1997), although less than previous surveys of 
patients registered with GPs in this area (Marshall et al., 2013). When response rates are low, 
respondents may not necessarily be representative of the wider community (Hill et al., 1997), 
although a systematic review found no effect of response rate on recorded prevalence of anxiety 
disorders (Baxter, Scott, Vos, & Whiteford, 2013). We consider the results of this survey to be 
generalizable to UK primary care populations presenting with joint pain due to the sampling frame 
used, response rate, and clinical anxiety prevalence comparable to previous evidence (Stubbs et al., 
2016).  
 
The instruments used in the survey considered different timescales: GAD-7 questions consider the 
previous two weeks, the numeric pain scales covered the previous month, and the KNEST included 
treatments over the previous twelve months. Clinical anxiety symptoms tend to be chronic (Spitzer 
et al., 2006), but joint pain is reported as being variable over days and weeks (Gooberman-Hill et al., 
2007). The use of a single cross-sectional questionnaire precludes the drawing of conclusions 
regarding causal or temporal (direction of association) relationships between joint pain and anxiety 
symptoms. We were also unable to determine the effects of treatments taken previously. For 
example, respondents reporting high levels of analgesia use and low levels of pain equally might 
reflect successful management of pain or inappropriately high levels of analgesia, and respondents 
using adjunctive treatments for their joint pain may have tried core treatments previously and found 
them unsuccessful. Information provision was reported as poor, but for those with symptoms of 
several years’ duration, the information may have been provided more than one year ago. There 
was also a risk of recall bias. For example, treatments that were not successful might be recalled less 
than more successful interventions. Also, patients expecting a pharmacological intervention might 
be more likely to recall prescriptions they received than the provision of information. 
 
We performed multiple comparisons in this analysis. Although a number of significant results at the 
p<0.05 level would be expected by chance, the gradient of odds of clinical anxiety seen with 
increasing pain severity and number of pain sites, means that these observations are likely to be 
valid and in keeping with previous evidence (de Heer et al., 2014). We have controlled for multiple 
potential confounding factors, though residual confounding remains a risk. However, we consider 
that in the primary care setting, the mechanism linking anxiety with joint pain may be less important 
than recognising that a relationship exists and seeking to improve recognition of anxiety symptoms 
in OA patients. 
 
NICE guidance for the recognition of mental health problems highlights a need to be alert to the 
possibility of anxiety disorders (National Institute for Health and Care Excellence, 2011). As one in 
five patients presenting to their GP with joint pain has clinical anxiety as defined by a raised GAD-7 
score, with the anxiety increasing with pain severity and the number of sites affected, we consider 
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that this constitutes a population in which the routine use of a case-finding instrument for anxiety 
may be warranted. The GAD-7 scale, and even briefer two-item (Kroenke et al., 2007) and single-
item (Donker, van Straten, Marks, & Cuijpers, 2011) scales have similar properties for identifying 
patients for further assessment, with the two-item version being recommended by NICE (National 
Institute for Health and Care Excellence, 2011). Although routine use may identify many people with 
sub-threshold symptoms, as the first step in the treatment of generalised anxiety disorder is the 
identification and monitoring of symptoms (National Institute for Health and Care Excellence, 2011), 
we consider that it would be a proportionate and justifiable approach for this population. The 
Improving Access to Psychological Therapies services use a GAD-7 threshold score of 8 to define 
cases (Clark et al., 2009), so referral to these services could be offered to patients meeting the 
clinical anxiety threshold used in our study. 
 
Conclusions 
NICE guidance on the management of OA emphasises the importance of a self-management strategy 
and use of core treatments (National Institute for Health & Care Excellence, 2014). The majority of 
respondents with or without anxiety did not report adherence to these recommendations within the 
previous year. The broader MOSAICS programme is investigating the feasibility of improving access 
to core treatments (Dziedzic et al., 2014). As discussed, self-management and use of core treatments 
are particularly beneficial for patients with co-morbid anxiety, yet we have shown that they are least 
likely to be following this approach. We therefore propose that additional efforts are made by 
clinicians to encourage and facilitate patients with co-morbid anxiety to self-manage their pain with 
core non-pharmacological treatments, and that especial attention is paid to the application of 
guidelines in managing joint pain for those with co-morbid anxiety. 
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